Evidence map›Paper›PMID 41171023›Full record

ArticlePrenatal diagnosis2025

Clinical Trials of Fetal Therapy With Continuing Neonatal Interventions: Legal Requirements and Customary Procedures Regarding Parental Consent. The BOOSTB4 Trial as a Case Study.

Esther J Oldekamp, Martine C de Vries, Anna L David, Oliver Semler, Magnus Westgren, Cecilia Götherström, E J T Joanne Verweij

Abstract read
In one paragraph

Article in Prenatal diagnosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Esther J OldekampDepartment of Medical Ethics and Health Law, Leiden University Medical Centre, Leiden, the Netherlands.
Martine C de VriesDepartment of Medical Ethics and Health Law, Leiden University Medical Centre, Leiden, the Netherlands.
Anna L DavidElizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK.ORCID 0000-0002-0199-6140
Oliver SemlerDepartment of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Magnus WestgrenDepartment of Clinical Science, Intervention and Technology, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden.
Cecilia GötherströmDepartment of Clinical Science, Intervention and Technology, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden.
E J T Joanne VerweijDepartment of Obstetrics, Division of Fetal Therapy, Leiden University Medical Centre, Leiden, the Netherlands.

Funding

Foundation for Children of the Freemasons in StockholmHorizon 2020 Framework Programme 681045Region Stockholm in Sweden 20200365, FoUI-975495the Center for Innovative Medicine in Sweden FoUI-962010Vetenskapsrådet 2020-01666Vetenskapsrådet 921-2014-7209
6 · The paper itself

Abstract

objectiveTo analyze the legal consent requirements and customary procedures in clinical trials of fetal therapy with continuing neonatal interventions across four European countries using the BOOSTB4 trial as a case study.

methodsThe study of country-specific legal consent requirements and the actual consent procedures in the BOOSTB4 trial, incorporating surveys with the trial's principal investigators.

resultsPrenatal consent was obtained solely from the pregnant women in all participating countries, in line with legal requirements. However, in all countries both prospective parents were engaged in prenatal counseling. In Sweden, the Netherlands and Germany obtaining consent from both parents for continuing neonatal interventions is mandatory. In the United Kingdom, officially only the consent of one parent is required. Nevertheless, researchers there are cautious of including pregnant women or neonates if parents disagree to trial participation, a concern echoed by Dutch, German and Swedish researchers.

conclusionWhile the pregnant woman's autonomy is paramount for prenatal trial participation, trials involving continuing neonatal interventions should adopt a two-step prenatal counseling approach. This approach allows a distinction between consent for fetal and neonatal procedures and allows researchers to comprehend parental perspectives without undermining the pregnant woman's individual rights.

Indexed as

Clinical Trials as TopicFetal TherapiesInformed ConsentParental ConsentEuropeFemaleHumansInfant, NewbornNetherlandsPregnancySweden

Identifiers

PMID41171023
PMCPMC12692989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.